	Assessing the concordance between ChatGPT-4 and EAU guidelines indications in bladder cancer management: a real-world study. Minerva Urol Nephrol Lo Re M, Cadenar A, Pezzoli M, Mancon S, Fuligni E, Lambertini L, Carlino A, Catanzaro R, DI Dio M, Minervini A, Cocci A. PMID: 42438987 [PubMed - indexed for MEDLINE]
	Preliminary feasibility of SHURUI single-port robot-assisted radical cystectomy with exploratory comparison to a contemporaneous da Vinci Xi single-port cohort. Minerva Urol Nephrol Zhu Q, Wang J, Wei Y, Liu W, Shen L, Fankhauser CD, Gu M. PMID: 42438984 [PubMed - indexed for MEDLINE]
	Off-clamp and on-clamp robotic-assisted partial nephrectomy in ischemia-sensitive patients: a multicenter propensity score-matched study (RAPN OFF-CLAMP study - UroCCR 187). Minerva Urol Nephrol Schurdi-Levraud L, Margue G, Geshkovska A, Bensalah K, Ricolleau C, Bruyere F, Champy C, Michel C, Surlemont L, Fantoni JC, Fontenil A, Sarrazin C, Beauval JB, Parier B, Panthier F, Patard JJ, Belas O, Bigot P, Bernhard JC. PMID: 42438983 [PubMed - indexed for MEDLINE]
	First report of safety and outcomes of radiofrequency ablation of renal tumors using a new automated energy delivery-controlled system. Minerva Urol Nephrol Ferrillo G, Baldassarre E, Sirugo T, Romano S, Lanza E, Poretti D, Saita A, Levi R, Lughezzani G, Buffi NM, Casale P, Francone M, Pedicini V. PMID: 42438982 [PubMed - indexed for MEDLINE]
	Perioperative safety and short-term survival outcomes of radical nephrectomy with thrombectomy in geriatric renal cell carcinoma patients with venous tumor thrombus. Minerva Urol Nephrol Guan Y, Hong P, Xiao R, Tang S, Liu Z, Tian X, Wang G, Ma L, Zhang H, Zhang S. PMID: 42438981 [PubMed - indexed for MEDLINE]
	YAU-RCC spotlight: where evidence ends and consensus begins for renal cell carcinoma. Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025. Minerva Urol Nephrol Mollica V, Yekedüz E, Amparore D, Campi R, European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group. PMID: 42438977 [PubMed - in process]
	Incidence and Spectrum of Adverse Events With Enfortumab Vedotin Therapy in Advanced or Metastatic Urothelial Carcinoma: Evidence From a Systematic Review and Meta-Analysis. Arch Esp Urol Li X, Leng W, Hu W, Gao D, Zhu Z, Lin J, Xu C. PMID: 42438880 [PubMed - indexed for MEDLINE]
	Age as a Predictor of Prostate Cancer Risk Stratification in Systematic Prostate Biopsy. Arch Esp Urol Bostanci C, Erdem K. PMID: 42438876 [PubMed - indexed for MEDLINE]
	Survival in Synchronous Versus Metachronous Bladder and Prostate Cancer. Arch Esp Urol Yalç, Tuncay E, Arslan S, Araci HE, Köseo. PMID: 42438875 [PubMed - indexed for MEDLINE]
	Radiologic and Lipid Metabolism Imaging Features Associated with FABP2 Expression in Clear Cell Renal Cell Carcinoma: An Interpretable Supervised Machine Learning Radiogenomic Study. Arch Esp Urol Greco F, Cataldo M, Panunzio A, Tafuri A, Beomonte Zobel B, Mallio CA. PMID: 42438874 [PubMed - indexed for MEDLINE]
	Immunohistochemistry-Based Molecular Subtyping in Muscle-Invasive Bladder Cancer: Predicting Response to Neoadjuvant Chemotherapy. Arch Esp Urol Pérez-Bartivas L, Leiva-Cepas F, Ponferrada D, Flores-Paco P, Atance-Morales V, Martínez M, Armenta-Triviño A, Rodríguez-Alonso RM, De La Haba-Rodríguez J, Aranda E, Méndez-Vidal MJ. PMID: 42438872 [PubMed - indexed for MEDLINE]
	Magnetic Resonance Imaging as a Predictor of Early Discontinuation of Active Surveillance in Patients with Prostate Cancer. Arch Esp Urol Domínguez Argomedo R, de Pablos-Rodríguez P, Pelechano Gómez P, Martín García MI, Arrizabalaga Solano A, Rodríguez Part V, Beamud Cortés M, Calatrava Fons A, Gutiérrez Castañé C, Gómez-Ferrer Lozano Á, García Cortés Á, López Gonzalez JA, Domínguez Escrig JL, Romero Hinostroza C, Sánchez Aparisi E, Casanova Ramón-Borja J. PMID: 42438871 [PubMed - indexed for MEDLINE]
	Androgen Deprivation Therapy and Cardiovascular Health: Challenges and Opportunities in Prostate Cancer Care. Arch Esp Urol Fernández Alonso S, López Campos F, Büchser D, Guardado S, Andreescu J, Vásquez W, Castaño A, Gil Moradillo J, García González L, Loblaw A, Couñago F. PMID: 42438869 [PubMed - indexed for MEDLINE]
	Impact of 3D-Assisted Preoperative Planning on Surgical and Functional Outcomes of Partial Nephrectomy in Adults: A Systematic Review. Arch Esp Urol Sanchez-Pedreno Jimenez M, Campos-Valverde D, Gabriela Arcadi A, Donis Canet F, Serret de Troya C, Tellez Martinez-Fornes M. PMID: 42438868 [PubMed - indexed for MEDLINE]
	Physical Activity During Radiotherapy in Prostate Cancer: Feasibility, Outcomes, and Clinical Integration. Arch Esp Urol Gil AMS, Tórtola-Navarro A, Blanco-Villar ML, Generoso RC, Prados AL, Mesa NAL, Galvez AS. PMID: 42438867 [PubMed - indexed for MEDLINE]
	Standardization of prostate-specific antigen assays: Impact on reference intervals and clinical decision thresholds. Tumour Biol Filella X. PMID: 42438220 [PubMed - indexed for MEDLINE]
	Mixed Response to Nivolumab Among Different Metastatic Sites in Patients With Metastatic Renal Cell Carcinoma: Incidence and Clinical Implications. Int J Urol Ishikawa Y, Tanaka H, Yamaguchi Y, Maruyama R, Fukuda S, Waseda Y, Inoue M, Yoshida S, Matsuoka Y, Numao N, Fujii Y. PMID: 42438108 [PubMed - indexed for MEDLINE]
	Targeted proteomics for the detection of androgen receptor variants in preclinical models of castration-resistant prostate cancer. Clin Proteomics Sychev ZE, Larson G, Ludwig ML, Shiba S, Tietz K, Russo JW, Balk S, Corey E, Plymate S, Antonarakis ES, Dehm SM, Seegmiller JC, Drake JM. PMID: 42437885 [PubMed - as supplied by publisher]
	Prostate-specific membrane antigen based diagnostic and therapeutic integration for prostate cancer management. Discov Oncol Dixit T, Sawardekar M, Verma T, Sreeja P, Ravindran S. PMID: 42437859 [PubMed - as supplied by publisher]
	Clinical pathological changes in prostate cancer patients after hormonal therapy: A single-center pilot study. Biochem Biophys Rep Magar RW, Sadeq MR, El-Halawani S, Karras MS. PMID: 42437084 [PubMed]

Articles 1 - 20 / 179951

Page 1 of 8998



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy